Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40

Background: Complex local and systemic immune dysfunction in glioblastoma (GBM) may affect survival. Interleukin (IL)-6 and YKL-40 are pleiotropic biomarkers present in the tumor microenvironment and involved in immune regulation. We therefore analyzed plasma IL-6, YKL-40, and genetic variation in Y...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Holst, Camilla Bjørnbak, Christensen, Ib Jarle, Skjøth-Rasmussen, Jane, Hamerlik, Petra, Poulsen, Hans Skovgaard, Johansen, Julia Sidenius
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7180208/
https://ncbi.nlm.nih.gov/pubmed/32363159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00478
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados